Richard Aranda - 22 Jun 2022 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Chief Medical Officer
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
22 Jun 2022
Net transactions value
-$12,233
Form type
4
Filing time
23 Jun 2022, 18:47:07 UTC
Previous filing
17 Mar 2022
Next filing
25 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOSS Common Stock Sale $12,233 -1,778 -0.84% $6.88* 209,897 22 Jun 2022 Direct F1, F2
holding GOSS Common Stock 2,539 22 Jun 2022 By family trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $6.88 to 7.13 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.